Global Mice Model Market: Arising COVID-19 pendamic situation and increasing demand for effective therapeutic drugs have positively impacted the market growth.

Published Date: 11/05/2021

The mouse is a mammal with genetic tools that are sophisticated and their genetic resources are very significant, hence it is used as a popular model system. In order to explore the human pathophysiology and the progression of the diseases, the mice are the best model for this purpose. New models are being developed in which the human cells and tissues are being reconstituted. As most of their genes are shared with humans new opportunities are getting opened up for the genetic testing.
the Global Mice Model Market was valued at USD 1,375.6 Million in 2020 and is expected to witness a growth of 7.67% from 2020-2027 and reach USD 2,315.5 Million by 2027.

The global mice model market has been growing at a healthy rate and is likely to continue at the same pace in the near future. A significant rise in the biomedical research in the healthcare and pharmaceutical sector is anticipated to accelerate the growth of the global market in the forecast period. The expansion of the application base and the rising competition among the leading players are projected to supplement the growth of the global mice model market in the next few years.

The global mice model market is expanding on account of the striking relevance of these models in performing biomedical research. Since the genetics, physiology, and anatomy of mice is perplexingly similar to that of humans, mice models are extensively used for conducting several researches concerned with the human body. In recent times, the discovery of new drug molecules is followed by their testing on samples of mice, which is in turn followed by inferences about human diagnostics. Moreover, the mechanism of several diseases in the human body can be compared to that of mice.

The mice model market is globally segmented into its type, technology, application, and service. On the basis of type, the global mice model market is segregated into genetically engineered mice, hybrid/congenic mice, spontaneous mutant mice, inbred mice, conditioned/surgically modified mice, and outbred mice. Based on the technology, the market is categorized into microinjection, nuclear transfer, genetically modified sperm-mediated gene transfer, electroporation of DNA & liposome-mediated DNA, CRISPR, embryonic stem cell injection, virus/vector-mediated gene transfer, biolistics, & TALENs & ZFN. The various applications where the mice model is used include immunology and inflammation studies, cardiovascular studies, rare diseases, toxicology, oncology studies, diabetes studies, central nervous system studies, renal disorders, hematopoiesis, and others. On the basis of services, the market is divided into cryopreservation, rederivation model in licensing, surgical, in vivo pharmacology services, breeding services, quarantine, genetic testing, and line rescue.

Region-wise, the global mice model market is diversified into regions such as North America, Asia-Pacific, Europe, and Rest of the World. The region that dominates the global mice model market is the North America. This dominance is going to continue in the coming years too owing to the presence of the large pharmaceutical sectors in the North American region and also there are tremendous research and development activities that are done in this region. Europe holds the second leading position in the global market. The increasing demand for the knockout and transgenic mice models attributes to the mice model market growth in the Asia-Pacific region. The countries that contribute a major share in the market growth are China, Malaysia, India, and Singapore.

Key industry players operating in the mice model market include genOway, Envigo, Charles River, Janvier Labs, Transviragen Inc., Transpogen Biopharmaceutical, Inc., and Taconic Biosciences Inc.